Northern Trust
VTVT icon

Northern Trust’s vTv Therapeutics VTVT Stock Holding History

Northern Trust’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$716K Buy
18,052
+2,000
+12% +$72.6K ﹤0.01% 3474
2025
Q4 		$642K Buy
16,052
+1,980
+14% +$55.1K ﹤0.01% 3562
2025
Q3 		$329K Sell
14,072
-1,215
-8% -$21.3K ﹤0.01% 3795
2025
Q2 		$229K Sell
15,287
-339
-2% -$6.21K ﹤0.01% 3888
2025
Q1 		$271K Buy
+15,626
New +$261K ﹤0.01% 3830
2023
Q4 		– Sell
-1,260
Closed -$24.1K – 4551
2023
Q3 		$24.1K Hold
1,260
– – ﹤0.01% 4303
2023
Q2 		$37.3K Buy
1,260
+246
+24% +$7.82K ﹤0.01% 4286
2023
Q1 		$32.8K Hold
1,014
– – ﹤0.01% 4360
2022
Q4 		$26.9K Hold
1,014
– – ﹤0.01% 4422
2022
Q3 		$39K Hold
1,014
– – ﹤0.01% 4396
2022
Q2 		$30K Hold
1,014
– – ﹤0.01% 4556
2022
Q1 		$29K Hold
1,014
– – ﹤0.01% 4627
2021
Q4 		$40K Hold
1,014
– – ﹤0.01% 4627
2021
Q3 		$62K Hold
1,014
– – ﹤0.01% 4494
2021
Q2 		$93K Sell
1,014
-3,064
-75% -$310K ﹤0.01% 4380
2021
Q1 		$460K Buy
4,078
+566
+16% +$55.6K ﹤0.01% 3839
2020
Q4 		$262K Buy
3,512
+92
+3% +$7.05K ﹤0.01% 3903
2020
Q3 		$243K Sell
3,420
-59
-2% -$5.18K ﹤0.01% 3777
2020
Q2 		$313K Buy
3,479
+2,995
+619% +$296K ﹤0.01% 3647
2020
Q1 		$37K Buy
484
+179
+59% +$17.2K ﹤0.01% 4000
2019
Q4 		$21K Hold
305
– – ﹤0.01% 4153
2019
Q3 		$19K Hold
305
– – ﹤0.01% 4155
2019
Q2 		$17K Hold
305
– – ﹤0.01% 4186
2019
Q1 		$21K Sell
305
-489
-62% -$47.4K ﹤0.01% 4128
2018
Q4 		$84K Buy
794
+7
+0.9% +$648 ﹤0.01% 3959
2018
Q3 		$24K Sell
787
-528
-40% -$24.8K ﹤0.01% 4211
2018
Q2 		$81K Sell
1,315
-1,090
-45% -$80.5K ﹤0.01% 4050
2018
Q1 		$391K Buy
2,405
+479
+25% +$117K ﹤0.01% 3634
2017
Q4 		$463K Sell
1,926
-3
-0.2% -$673 ﹤0.01% 3577
2017
Q3 		$462K Sell
1,929
-4
-0.2% -$797 ﹤0.01% 3582
2017
Q2 		$384K Sell
1,933
-15
-0.8% -$3.13K ﹤0.01% 3637
2017
Q1 		$510K Sell
1,948
-143
-7% -$32.6K ﹤0.01% 3534
2016
Q4 		$404K Buy
2,091
+59
+3% +$13.6K ﹤0.01% 3583
2016
Q3 		$584K Buy
2,032
+16
+0.8% +$3.85K ﹤0.01% 3472
2016
Q2 		$468K Buy
2,016
+535
+36% +$123K ﹤0.01% 3531
2016
Q1 		$306K Buy
1,481
+32
+2% +$7.97K ﹤0.01% 3597
2015
Q4 		$395K Buy
1,449
+1,107
+324% +$311K ﹤0.01% 3565
2015
Q3 		$89K Buy
+342
New +$119K ﹤0.01% 3957

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Northern Trust's VTVT Position: Q1 2026 in Review

Northern Trust increased its vTv Therapeutics (VTVT) stake by 12% in Q1 2026, buying an estimated $72.6K and bringing the position to 18,052 shares worth $716K. The position accounts for ﹤0.01% of the portfolio, ranked #3474.

Northern Trust first reported a position in VTVT in Q3 2015 and has held it in 38 quarters since. 35 funds tracked by Wall St. Rank hold VTVT as of Q1 2026.

  • Northern Trust held 18,052 shares of vTv Therapeutics worth $716K as of Q1 2026.
  • Northern Trust bought 2,000 vTv Therapeutics shares in Q1 2026, an estimated $72.6K.
  • vTv Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3474 holding.
  • Northern Trust first reported a position in vTv Therapeutics in Q3 2015 and has held it in 38 quarters since.
  • 35 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.